Skip to content
GCC AI Research

Search

Results for "Immune system"

Multimodal single-cell atlas for ancestry-based diversity of immune system

MBZUAI ·

The Russian Immune Diversity Atlas project aims to profile immune cells from people of different ancestries at a multiomics level. The goal is to reconstruct a reference atlas of the healthy immune system and investigate its perturbations in Type II Diabetes (T2D). The project seeks to identify novel mechanisms and genetic/epigenetic markers for early T2D diagnostics, prognosis, and therapy as part of the international Human Cell Atlas. Why it matters: Addressing genetic diversity in biomedical research, particularly in the context of the Human Cell Atlas, is crucial for personalized medicine and ensuring that treatments are effective across diverse populations in the Middle East and globally.

New discovery boosts wheat's fight against devastating disease

KAUST ·

KAUST researchers have discovered the first molecular events that trigger wheat's immunity to stem rust, a devastating fungal disease. The study, published in Science, identifies that tandem kinases are bound together and inactive until a pathogen binds, initiating an immune response that kills the infected cell. This prevents the pathogen from spreading and causing widespread crop damage. Why it matters: Understanding these molecular mechanisms could lead to engineering wheat with stronger and more durable resistance to stem rust and other diseases, safeguarding a crucial food source in the face of climate change and emerging pathogens.

Hacking the SARS-CoV-2 genome

KAUST ·

KAUST researchers are analyzing the SARS-CoV-2 genome to identify potential targets for treatment and vaccine development. They are using the KAUST Metagenome Analysis Platform (KMAP) and the university's supercomputer to compare and analyze genomic data. The research focuses on identifying key genes for detection and treatment of COVID-19. Why it matters: This research contributes to the global effort to combat the pandemic and highlights KAUST's capabilities in genomic data analysis and computational bioscience.

A shock to the system

KAUST ·

KAUST Professor Hernando Ombao is leading the Biostatistics Group to develop statistical models for projecting hospitalization surges during the COVID-19 pandemic. The group uses techniques like time series analysis and stationary subspace analysis to understand complex biological processes. The models aim to provide public health officials with accurate hospitalization estimates under varying scenarios. Why it matters: This research contributes to preparedness and resource allocation in healthcare systems during public health crises, with potential applications beyond COVID-19.

Nanoscale drug factory helps cells make medicine from within

KAUST ·

Scientists at King Abdullah University of Science and Technology (KAUST) have engineered tiny metal-organic frameworks (MOFs) to deliver a team of six proteins into living cells. Inside the cells, these proteins formed a nanoscale factory that successfully produced violacein, a natural bioactive compound with therapeutic potential. This breakthrough represents the most complex multiprotein system delivered into living cells to date and the first example of a 'protein pathway transplant'. Why it matters: This research offers an early demonstration of how future therapies might generate treatment molecules directly inside the body at disease sites, potentially leading to more precise and less toxic medical interventions.